Trial intelligence / Profile preview

Amoxicillin vs Placebo in Alveolar Bone Grafting

NCT07296302Not yet recruiting

Start
Feb 2026
Primary completion
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in surgical site infection (SSI) comparing Amoxicillin Prophylaxis Group with Placebo Group (2 arms). Primary endpoint: Incidence of postoperative infection at 30 days. Planned start Feb 2026; status: not yet recruiting.

02

Drugs

amoxicillin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT07296302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07296302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call